Ippocastano

Aesculus hippocastanum L.

Bibliografia

  • Bloyer WE. (1898) Eclectic Medical Journal.;LVI(8):375-376
  • Ehringer (1968) Arzneim-Forsch; 18(4): 432-434
  • Enghofer et al (1984) Therapiewoche; 34(27): 4130-4144
  • Facino RM, Carini M, Stefani R, Aldini G, Saibene L (1995) Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch Pharm (Weinheim);328(10):720-4
  • Felter H and Lloyd JU. (1898) King’s American Dispensatory. Portland, Oregon: Eclectic Medical Publications.
  • Greeske K, Pohlmann BK. (1996) Horse chestnut seed extract—an effective therapy principle in general practice. Drug therapy of chronic venous insufficiency. Fortschr Med May 30;114(15):196-200
  • Guillaime et al. (1994) Arzneim-Forsch ; 44(1): 25-35.
  • Klemm (1982) Munch Med Wochenschr; 124: 579-582
  • Marshall et al (1987) Phlebology; 2:123-124
  • Masaki et al. (1995) Biol Pharm Bull; 18(1): 162-166
  • Matsuda H, Li Y, Murakami T, Ninomiya K, Yamahara J, Yoshikawa M. (1997) Effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol Pharm Bull ;20(10):1092-5
  • Moore M (1995) Medicinal plants of the pacific west. Red Crane Books, Santa Fe, USA
  • Paushinger (1984) Ergebnisse Angiolog; 30; 129-137
  • Paushinger et al (1974) Med Welt ; 25(14): 603-607.
  • Pittler MH, Ernst E. (1998 ) Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. Arch Dermatol;134(11):1356-60
  • Pittler MH, Ernst E. (2001) Alter Ther Health Med 7(3):108
  • Stevens, P.F. (2001 onwards). Angiosperm Phylogeny Website. Version 5, May 2004 [and more or less continuously updated since]. http://www.mobot.org/MOBOT/research/APweb/.